Skip to main
HZNP
HZNP logo

Horizon Pharma (HZNP) Stock Forecast & Price Target

Horizon Pharma (HZNP) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 18%
Buy 45%
Hold 36%
Sell 0%
Strong Sell 0%
Horizon Pharma (HZNP) has been analyzed by 22 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 45% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Horizon Pharma and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Horizon Pharma (HZNP) Forecast

Analysts have given Horizon Pharma (HZNP) a Buy based on their latest research and market trends.

According to 22 analysts, Horizon Pharma (HZNP) has a Buy consensus rating as of Jul 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Horizon Pharma (HZNP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.